Mechanistic Insights and Advances of Bispecific T Cell Engaging Antibodies Therapy in Multiple Myeloma

Ting Fang Tang, Chin Sum Cheong, Chung Yeng Looi, Won Fen Wong, Gin Gin Gan · 2025

Read Mechanistic Insights and Advances of Bispecific T Cell Engaging Antibodies Therapy in Multiple Myeloma by Ting Fang Tang, Chin Sum Cheong, Chung Yeng Looi, Won Fen Wong, Gin Gin Gan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12734887.txt.

Description

A peer-reviewed research article from Europe PMC (2025). Multiple myeloma (MM) is a clonal malignancy of terminally differentiated plasma cells characterized by bone marrow infiltration and excessive production of monoclonal immunoglobulins, leading to end-organ damage such as osteolytic bone lesions. Despite substantial therapeutic progress achieved with proteasome inhibitors, immunomodulatory drugs, and anti-CD38 monoclonal antibodies, multiple myeloma remains incurable, and outcomes for triple-class-refractory patients remain dismal, with median survival below one year.

Catalog record

CREATORTing Fang Tang, Chin Sum Cheong, Chung Yeng Looi, Won Fen Wong, Gin Gin Gan
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12734887

Browse the full library · About the Tower of Babel